Predictability of Gestational Diabetes Mellitus in First and Second Trimester (GDMPredict)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02035059

Recruitment Status : Completed

First Posted : January 14, 2014

Last Update Posted : April 26, 2019

Sponsor:

Collaborators:

University Hospital, Zürich

Cantonal Hospital of Aarau, Switzerland

Vienna General Hospital

Paracelsus Medical University

University Hospital Freiburg

Information provided by (Responsible Party):

University Hospital, Basel, Switzerland

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	December 31, 2018
Actual Study Completion Date :	December 31, 2018

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Huhn EA, Fischer T, Göbl CS, Todesco Bernasconi M, Kreft M, Kunze M, Schoetzau A, Dölzlmüller E, Eppel W, Husslein P, Ochsenbein-Koelble N, Zimmermann R, Bäz E, Prömpeler H, Bruder E, Hahn S, Hoesli I. Screening of gestational diabetes mellitus in early pregnancy by oral glucose tolerance test and glycosylated fibronectin: study protocol for an international, prospective, multicentre cohort trial. BMJ Open. 2016 Oct 12;6(10):e012115. doi: 10.1136/bmjopen-2016-012115.

To Top